# Merlin Biotech Inc.

Canonical: https://abierto.us/vendors/merlin-biotech-inc-u33szn8r3966

- UEI: U33SZN8R3966
- CAGE: 9K6A1
- Location: Doylestown, PA
- Awards in window: 1 (2 transactions), $300,000 obligated, September 16, 2025 to August 20, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $300,000

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $300,000

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91025C00025 (definitive contract): $300,000, NIH NCI. SBIR FY25 Concept Award, Development of an Immunotherapy for Ewing Sarcoma Using a Novel Murine Model. https://www.usaspending.gov/award/CONT_AWD_75N91025C00025_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/merlin-biotech-inc-u33szn8r3966.